Detalhe da pesquisa
1.
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Lancet Oncol
; 25(2): 255-264, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142702
2.
Multiparametric Magnetic Resonance Imaging in the follow-up of non-muscle-invasive bladder tumors after intravesical instillations: a promising tool.
World J Urol
; 42(1): 178, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507101
3.
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Lancet Oncol
; 24(7): 783-797, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414011
4.
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design.
Lancet
; 399(10336): 1695-1707, 2022 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405085
5.
A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study.
BMC Cancer
; 23(1): 393, 2023 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131154
6.
External validation of the computerized analysis of TRUS of the prostate with the ANNA/C-TRUS system: a potential role of artificial intelligence for improving prostate cancer detection.
World J Urol
; 41(3): 619-625, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35249120
7.
Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure.
World J Urol
; 41(11): 3195-3203, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811732
8.
Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(3): 393-405, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157830
9.
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 612-624, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390339
10.
Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study.
Int J Cancer
; 151(8): 1335-1344, 2022 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603906
11.
Self-reported functional assessment after treatment for prostate cancer: 5-year results of the prospective cohort VICAN.
Future Oncol
; 18(14): 1733-1744, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172586
12.
Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times.
Urol Int
; 106(2): 171-179, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34569540
13.
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.
N Engl J Med
; 379(5): 417-427, 2018 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29860937
14.
Metastatic hormone sensitive prostate cancer: local treatment strategies.
World J Urol
; 39(2): 327-337, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32588203
15.
Efficacy of HIVEC in patients with high-risk non-muscle invasive bladder cancer who are contraindicated to BCG and in patients who fail BCG therapy.
Int J Hyperthermia
; 38(1): 1633-1638, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775896
16.
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors.
Pharm Res
; 37(7): 147, 2020 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676789
17.
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
Lancet
; 391(10122): 748-757, 2018 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29268948
18.
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring.
Ther Drug Monit
; 41(1): 66-74, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30299429
19.
Computed tomography-guided percutaneous cryoablation of T1b renal tumors: safety, functional and oncological outcomes.
Int J Hyperthermia
; 36(1): 1065-1071, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648584
20.
Metastatic prostate cancer management: 20 years of progress.
Lancet Oncol
; 24(5): 416-417, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142365